Trial Profile
An open, prospective, single-arm study investigating safety and efficacy of the human hepatitis B immunoglobulin BT088 after subcutaneous application in liver transplanted patients Clinical Phase: III.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 01 Nov 2012
Price :
$35
*
At a glance
- Drugs Hepatitis B immune globulin (Primary)
- Indications Hepatitis B
- Focus Adverse reactions
- Sponsors Biotest AG
- 08 Aug 2011 New trial record